Connection

Martin Bachmann to Precision Medicine

This is a "connection" page, showing publications Martin Bachmann has written about Precision Medicine.
Connection Strength

0.093
  1. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.